PEPTID-PAC1-ANTAGONISTEN

Patent europeic · EP3630147 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3630147
Numer da la dumonda
EP18733107
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
01-06-2018
Publitgà
08-04-2020
Concedì
25-03-2026
La protecziun finescha il pli tard
31-05-2038
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
A61K 38/00 (2006.01)
Prioritad
US 201762514440 P 02.06.2017
Dumonda PCT
PCT/US2018/035597 01.06.2018
Publicaziun PCT
WO2018/222991 06.12.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 25-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.03.2026

Partidas

Inventur

CHEN, Irwin

Los Angeles California 90025, US

CHONG, Su

Oxnard California 93035, US

HARRINGTON, Essa Hu

Camarillo California 93012, US

HONG, Fang-Tsao

Thousand Oaks California 91360, US

LONG, Jason C.

Newbury Park California 91320, US

MIRANDA, Leslie P.

Thousand Oaks California 91362, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.